SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

29 hedge funds and large institutions have $225M invested in Sinovac Biotech, Ltd in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

0% less capital invested

Capital invested by funds: $225M → $225M (-$406K)

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$542
2
+$337

Top Sellers

1
-$284K
2
-$78.1K
3
-$45.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$184M
VC
2
Vivo Capital
California
$38.2M
NAH
3
Neumann Advisory (HK)
Hong Kong
$2.04M
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$106K
Morgan Stanley
5
Morgan Stanley
New York
$59.2K
Wells Fargo
6
Wells Fargo
California
$31.1K
UBS Group
7
UBS Group
Switzerland
$14.4K
HI
8
Horizon Investments
North Carolina
$673
HI
9
Harbour Investments
Wisconsin
$542
AWM
10
Aprio Wealth Management
Georgia
–